Read more about the article The American Psychiatric Association (APA) opposed mandatory neuropsychological testing for patients receiving electroconvulsive therapy (ECT).

ECT / FDA - 2016

The American Psychiatric Association (APA) opposed mandatory neuropsychological testing for patients receiving electroconvulsive therapy (ECT).

The America Psychiatric Association (APA) advocated against mandatory neuropsychological testing in the 2016 ECT device reclassification.

January 7, 2023

Read more about the article ECT Device Reclassification Draft Guidance – Moira Dolan MD to the FDA, 2016

ECT / ECT Side Effects & Risks / FDA / FDA - 2016

ECT Device Reclassification Draft Guidance – Moira Dolan MD to the FDA, 2016

Moira Dolan MD to the FDA regarding ECT draft guidance for the 2016 electroshock device risk reclassifacation.

September 18, 2022

Read more about the article ECT Safety Reclassification: Psych Rights to FDA

ECT / FDA / FDA - 2009 / FDA - 2016

ECT Safety Reclassification: Psych Rights to FDA

Psych Rights to FDA on the 2016 ECT device safety reclassification.

May 20, 2022

Read more about the article ECT Safety Reclassification: The Committee for Truth in Psychiatry to the FDA

ECT / FDA / FDA - 2016

ECT Safety Reclassification: The Committee for Truth in Psychiatry to the FDA

Linda Andre on behalf of the Committee for Truth in Psychiatry to the FDA, 2016 ECT device reclassification.

May 17, 2022